News articles

News article list

• NICE has made six times more lung cancer treatment recomendations over the past ten years than in the previous decade

  We have also recommended osimertinib for routine use on the NHS today.

• International collaboration provides new guidance on the use of surrogate endpoints in cost-effectiveness analysis

  Recommendations will help organisations that evaluate new drugs establish whether their use will result in longer-term benefits for patients

• NICE recommends new treatment to prevent and reduce hearing loss in people being treated for cancer

  For the first time, NICE has recommended an innovative new treatment to help stop babies, children and young people who are undergoing cancer treatment from losing their hearing.

• Over 1000 people with advanced breast cancer set to benefit from new once-a-day tablet

  We’ve issued final draft guidance recommending a new once-a-day tablet that is set to benefit around 1,100 people with a type of advanced breast cancer. 

• Public consultation launched on changes to NICE's Highly Specialised Technologies routing criteria

  NICE is proposing changes to its routing criteria for Highly Specialised Technologies (HST) to ensure more consistent, predictable and transparent decisions.

• New price deal paves way for NICE approval of treatment for rare genetic condition

  A new treatment for Duchenne muscular dystrophy (DMD) is set to be available to around 1,700 people in England following positive final draft guidance from NICE published today.